GlassScriptPhysician profile
Dong Kim
NPI 1942267992
$6,760.38
in general payments reported to CMS, 2019-2025
39 companies · $578 in 2025
The $578 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,221 · 2020: $1,166 · 2021: $1,278 · 2022: $874 · 2023: $1,049 · 2024: $595 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,221.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $857.23 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $792.20 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $775.90 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $523.45 | 2019-2025 | |
| Novo Nordisk INC | $466.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $408.22 | 2019-2025 | Ojjaara, Shingrix, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.91 | 2019-2023 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $298.02 | 2019-2025 | Xifaxan |
| Lilly USA, LLC | $291.81 | 2020-2023 | Mounjaro, Jardiance, Emgality |
| Allergan, INC. | $250.55 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $246.67 | 2019-2025 | Capvaxive, Gardasil, Gardasil 9 |
| Abbott Laboratories | $203.75 | 2021-2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $178.96 | 2019-2025 | |
| Aimmune Therapeutics, INC. | $124.30 | 2024 | |
| Eisai INC. | $114.69 | 2020-2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dong Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.